Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
RNA interference therapeutics targeting angiotensinogen ameliorate preeclamptic phenotype in rodent models
Nadine Haase, … , Babbette LaMarca, Ralf Dechend
Nadine Haase, … , Babbette LaMarca, Ralf Dechend
Published April 27, 2020
Citation Information: J Clin Invest. 2020;130(6):2928-2942. https://doi.org/10.1172/JCI99417.
View: Text | PDF
Research Article Reproductive biology

RNA interference therapeutics targeting angiotensinogen ameliorate preeclamptic phenotype in rodent models

  • Text
  • PDF
Abstract

Authors

Nadine Haase, Donald J. Foster, Mark W. Cunningham, Julia Bercher, Tuyen Nguyen, Svetlana Shulga-Morskaya, Stuart Milstein, Sarfraz Shaikh, Jeff Rollins, Michaela Golic, Florian Herse, Kristin Kräker, Ivo Bendix, Meray Serdar, Hanna Napieczynska, Arnd Heuser, Alexandra Gellhaus, Kristin Thiele, Gerd Wallukat, Dominik N. Müller, Babbette LaMarca, Ralf Dechend

×

Figure 5

siRNA against hAgt improves placenta morphology.

Options: View larger image (or click on image) Download as PowerPoint
siRNA against hAgt improves placenta morphology.
(A) Extension of tropho...
(A) Extension of trophoblast cell invasion was measured as the area of the mesometrial triangle invaded by trophoblast cells. This area was significantly increased in hAgt-targeting siRNA–treated (n = 9) preeclamptic (PE) rats compared with luciferase-targeting siRNA–treated (n = 10) rats (*P < 0.05; unpaired t test; mean ± SEM). (B) Representative pictures of cytokeratin-stained midsagittal mesometrial triangle (MT) and placental (P) tissue sections used to carry out the histomorphological analysis. Different zones of the placenta are marked: T, trophospongium; L, labyrinth. (C) The area of the mesometrial triangle was not different between luciferase-targeting siRNA– and hAGT-targeting siRNA–treated PE rats (mean ± SEM). (D) The overall size of the placenta was increased in hAgt-targeting siRNA–treated (n = 9) PE rats compared with luciferase-targeting siRNA–treated (n = 10) rats (*P < 0.05; unpaired t test; mean ± SEM). (E) The area of the trophospongium was not changed in hAgt-targeting siRNA–treated (n = 9) PE rats compared with luciferase-targeting siRNA–treated (n = 10) rats (mean ± SEM). (F) The area of the labyrinth zone of placentas of hAgt-targeting siRNA–treated (n = 9) PE rats was enhanced in comparison with luciferase-targeting siRNA–treated (n = 10) rats (*P < 0.05; unpaired t test; mean ± SEM). (G) Representative pictures of CD68-stained uteroplacental unit tissue sections. (H) The number of macrophages was increased in hAgt-targeting siRNA–treated (n = 9) PE rats compared with luciferase-targeting siRNA–treated (n = 9) rats. **P < 0.01; unpaired t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts